Characterization of a point mutation in aspartylglucosaminidase gene: evidence for a readthrough of a translational stop codon.
We have identified a novel aspartylglucosaminuria (AGU) mutation in the second exon of the aspartylglucosaminidase (AGA) gene resulting in a lysosomal storage disease in a Puerto Rican pedigree. This T192-->A transversion causes replacement of Cys64 with a premature translational stop codon and the patients' fibroblasts exhibit dramatically decreased steady-state levels of AGA mRNA. Immunofluorescence analysis and analysis of immunoprecipitated metabolically labelled AGA polypeptides from patient fibroblasts unexpectedly revealed traces of normally sized inactive AGA precursor polypeptide instead of the predicted short polypeptide of 40 amino acids, thus demonstrating readthrough due to suppression of the premature translational stop codon. The translated AGA precursor is not processed further and remains inactive. The Cys64 substitution evidently disturbs the folding of the nascent polypeptide in the endoplasmic reticulum, thus preventing activation by proteolytic cleavage.
Peltola
M
M
Department of Human Molecular Genetics, National Public Health Institute, Helsinki, Finland.
Chiatayat
D
D
Peltonen
L
L
Jalanko
A
A
D000595:Amino Acid Sequence; D001227:Aspartylglucosylaminase / Q000235:genetics* / Q000378:metabolism; D001483:Base Sequence; D002648:Child; D002894:Chromosomes, Human, Pair 4 / Q000235:genetics; D018388:Codon, Terminator / Q000235:genetics*; D004200:Diseases in Twins / Q000235:genetics; D005091:Exons; D006801:Humans; D016464:Lysosomal Storage Diseases / Q000201:enzymology / Q000235:genetics*; D008969:Molecular Sequence Data; D017354:Point Mutation / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics
D018388:Codon, Terminator; D012333:RNA, Messenger; D001227:Aspartylglucosylaminase